TY - JOUR
T1 - Facile, fast and green synthesis of a highly porous calcium-syringate bioMOF with intriguing triple bioactivity
AU - Rosado, Albert
AU - Vallcorba, Oriol
AU - Vázquez-Lasa, Blanca
AU - García-Fernández, Luís
AU - Ramírez-Jiménez, Rosa Ana
AU - Aguilar, María Rosa
AU - López-Periago, Ana M.
AU - Domingo, Concepción
AU - Ayllón, José A.
N1 - Publisher Copyright:
© 2023 The Royal Society of Chemistry.
PY - 2023/3/2
Y1 - 2023/3/2
N2 - A facile, fast and green strategy based on ethanol is utilized to prepare a new bioMOF, namely, CaSyr-1, with particular characteristics of full biocompatibility given by using just calcium and syringic acid, the latter being a phenolic natural product found in fruits and vegetables, permanent porosity with an outstanding surface area >1000 m
2 g
−1, and a micropore diameter of 1.4 nm close to mesopore values. Collectively, these data establish CaSyr-1 as one of the most porous bioMOFs reported to date, with high molecular adsorption capacity. The CaSyr-1 adsorptive behavior is revised here through the reversible adsorption of CO
2 and the encapsulation of bioactive ingredients in the structure. Remarkably, CaSyr-1 enables the development of triple therapeutic entities, involving bioactive Ca
2+, syringic acid and an impregnated drug.
AB - A facile, fast and green strategy based on ethanol is utilized to prepare a new bioMOF, namely, CaSyr-1, with particular characteristics of full biocompatibility given by using just calcium and syringic acid, the latter being a phenolic natural product found in fruits and vegetables, permanent porosity with an outstanding surface area >1000 m
2 g
−1, and a micropore diameter of 1.4 nm close to mesopore values. Collectively, these data establish CaSyr-1 as one of the most porous bioMOFs reported to date, with high molecular adsorption capacity. The CaSyr-1 adsorptive behavior is revised here through the reversible adsorption of CO
2 and the encapsulation of bioactive ingredients in the structure. Remarkably, CaSyr-1 enables the development of triple therapeutic entities, involving bioactive Ca
2+, syringic acid and an impregnated drug.
UR - http://www.scopus.com/inward/record.url?scp=85151014517&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/0a920412-aee2-3b5e-950b-b92b3bd6b955/
U2 - 10.1039/d2qi02639b
DO - 10.1039/d2qi02639b
M3 - Article
SN - 2052-1545
VL - 10
SP - 2165
EP - 2173
JO - Inorganic Chemistry Frontiers
JF - Inorganic Chemistry Frontiers
IS - 7
ER -